ArticleCancer management and research2025

Immunotherapy Rechallenge of Advanced NSCLC with Acquired EGFR T790M Mutation after EGFR-TKI Therapy: A Case Report.

Yiqing Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.